Pancreatic Cancer Cell and Gene Biotherapies: Past, Present, and Future-Reference-Cited by-同舟云学术

Pancreatic Cancer Cell and Gene Biotherapies: Past, Present, and Future

Published:2023-02-01 Issue:3-4 Volume:34 Page:150-161
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Quillien Lorraine¹,Buscail Louis¹²,Cordelier Pierre¹^ORCID

Affiliation:

1. Team Therapeutic Innovation in Pancreatic Cancer, CRCT, University of Toulouse, Inserm, CNRS, University of Toulouse III-Paul Sabatier, Cancer Research Centre of Toulouse, Toulouse, France.

2. Department of Gastroenterology and Pancreatology, Hôpital Rangueil, CHU de Toulouse, University Toulouse Paul Sabatier, Toulouse, France.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/hum.2022.210

Reference71 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer

3. Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects

4. Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minute virus of mice shows oncolytic activity against pancreatic cancer cells exhibiting a mesenchymal phenotype;Molecular Therapy: Oncology;2024-03

2. Pancreatic cancer: the insidious, deadly malignancy;Prescriber;2023-11

3. Minute virus of mice is oncolytic for pancreatic cancer cells with mesenchymal phenotype;2023-04-12